Tenet Healthcare Corporation (NYSE:THC – Get Free Report) Director Richard Mark sold 10,000 shares of the business’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $263.42, for a total value of $2,634,200.00. Following the sale, the director owned 25,121 shares in the company, valued at approximately $6,617,373.82. This trade represents a 28.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Tenet Healthcare Trading Up 0.4%
Shares of NYSE THC traded up $1.16 during trading on Monday, reaching $264.85. The company had a trading volume of 618,667 shares, compared to its average volume of 712,145. The company’s fifty day moving average price is $246.18 and its 200-day moving average price is $212.44. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The stock has a market cap of $21.33 billion, a P/E ratio of 10.21, a PEG ratio of 1.01 and a beta of 1.23. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $283.05.
Tenet Healthcare (NYSE:THC – Get Free Report) last released its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. The business had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. Tenet Healthcare’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 21.04 earnings per share for the current year.
Institutional Trading of Tenet Healthcare
Analyst Ratings Changes
THC has been the topic of several research reports. Guggenheim upped their price objective on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a report on Tuesday, July 28th. Weiss Ratings raised Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, August 20th. Wells Fargo & Company increased their price objective on Tenet Healthcare from $231.00 to $281.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. The Goldman Sachs Group restated a “buy” rating and issued a $305.00 price objective on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Finally, Zacks Research upgraded shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $275.53.
Check Out Our Latest Report on THC
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women’s health and other inpatient and outpatient treatments.
Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities.
Read More
- Five stocks we like better than Tenet Healthcare
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
